A detailed history of Allworth Financial LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Allworth Financial LP holds 1,462 shares of ADPT stock, worth $11,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,462
Previous 1,639 10.8%
Holding current value
$11,710
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$3.37 - $5.12 $596 - $906
-177 Reduced 10.8%
1,462 $7,000
Q2 2024

Jul 23, 2024

BUY
$2.34 - $3.96 $2,541 - $4,300
1,086 Added 196.38%
1,639 $5,000
Q1 2024

Apr 25, 2024

BUY
$2.88 - $4.8 $1,592 - $2,654
553 New
553 $1,000
Q3 2023

Oct 31, 2023

SELL
$5.07 - $8.44 $116 - $194
-23 Reduced 48.94%
24 $0
Q2 2023

Jul 18, 2023

BUY
$6.19 - $8.78 $148 - $210
24 Added 104.35%
47 $0
Q1 2023

Apr 18, 2023

BUY
$7.8 - $10.11 $179 - $232
23 New
23 $0
Q3 2022

Oct 18, 2022

BUY
$6.5 - $12.67 $149 - $291
23 New
23 $0

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.14B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.